31 JAN 2017: Orange County, CA – Vivonoetics Inc., developer of VivoSense® respiratory testing solutions, announced today that in partnership with Great Lakes NeuroTechnologies, they will be providing advanced respiratory assessment to the Roche FIREFISH study
Infants with Spinal muscular atrophy (SMA) develop respiratory insufficiency due to progressive respiratory muscle weakness caused by degeneration of alpha motor neurons in the spinal cord.
…
11 JAN 2017: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has been awarded Patent 9,522,278 (Movement Disorder Therapy System and Methods of Tuning Remotely, Intelligently and/or Automatically) from the US Patent Office, the seventh patent awarded to the company in 2016,
…
26 SEPT 2016: Valley View, OH – Great Lakes NeuroTech (GLNT) today announced plans to collaborate with the pharmaceutical company UCB to provide individuals with Parkinson’s Disease (PD) and their clinicians with improved quantitative tools for assessing the impact of their current treatment with the aim of providing better individual patient experiences and,
…
20 JUL 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) has completed and published a clinical study validating that remote monitoring with wearable, objective measures can lead to an increased referral rate for advanced therapies in Parkinson’s disease. The study “Wearable Sensors for Advanced Therapy Referral in Parkinson’s Disease,” was recently published in The Journal of Parkinson’s Disease [ http://www.ncbi.nlm.nih.gov/pubmed/27392872 ].
…
15 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that three scientific research studies validating Kinesia wearable tech for Parkinson’s disease applications will be highlighted at the 20th International Congress of Parkinson’s Disease and Movement Disorders in Berlin,
…
10 JUN 2016: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they 
have received four issued patents from the U.S. Patent Office, focused on wearable technology for Parkinson’s disease diagnostics and treatment. The issued intellectual property covers using wearable sensors for measuring motor symptoms associated with Parkinson’s disease,
…
14 OCT 2015: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they have received a new allowance of claims from the U.S. Patent Office, focused on technology for Parkinson’s disease diagnostics and treatment. This particular application covers a method of measuring Parkinson’s motor symptoms such as tremor,
…
21 SEP 2015: Cleveland, OH – Great Lakes NeuroTechnologies (GLNT), announced they have received $1.9M from the National Institutes of Health to improve the efficacy of deep brain stimulation (DBS) programming for Parkinson’s disease (PD) and minimize time required by a clinician to optimize settings.
…
17 MAR 2015: Cleveland, OH – While headlines recently surged over big organizations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson’s disease… a small,
…
06 FEB 2015: Valley View, OH – Great Lakes NeuroTechnologies announced today they have completed two pilot studies [ http://glneurotech.com/kinesia/validation/dbs-pilot-study/ ] demonstrating computer-guided algorithms for programming deep brain stimulation (DBS) in Parkinson’s disease. The first study, in collaboration with the University of Minnesota and recently accepted for publication in Parkinsonism and Related Disorders [ http://glneurotech.com/kinesia/publications/ ],
…
